“[Cost-Effectiveness Analysis of Peginterferon Beta-1a in Italian Relapsing Remitting Multiple Sclerosis Management]”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 17, no. 2S, July 2016, pp. 13-36, https://doi.org/10.7175/fe.v17i2S.1230.